The Relationship between Substance Use Stigma and COVID-19 Vaccine Hesitancy.
| Title: | The Relationship between Substance Use Stigma and COVID-19 Vaccine Hesitancy. |
|---|---|
| Authors: | Powell N; Pritzker School of Medicine, University of Chicago, Chicago, IL 60637, USA.; Taylor B; NORC at the University of Chicago, Chicago, IL 60637, USA.; Hotton A; Departments of Medicine and Public Health, University of Chicago, Chicago, IL 60637, USA.; Lamuda P; NORC at the University of Chicago, Chicago, IL 60637, USA.; Flanagan E; NORC at the University of Chicago, Chicago, IL 60637, USA.; Pyra M; Department of Medical Social Sciences, Northwestern University, Evanston, IL 60201, USA.; Brewer R; Department of Medicine, University of Chicago, Chicago, IL 60637, USA.; Johnson O; Southern Public Health and Criminal Justice Research Center, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.; Pollack HA; Crown Family School of Social Work, Policy, and Practice, University of Chicago, Chicago, IL 60637, USA.; Schneider JA; Departments of Medicine and Public Health, University of Chicago, Chicago, IL 60637, USA. |
| Source: | Vaccines [Vaccines (Basel)] 2023 Jul 03; Vol. 11 (7). Date of Electronic Publication: 2023 Jul 03. |
| Publication Type: | Journal Article |
| Language: | English |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE |
| Imprint Name(s): | Original Publication: Basel, Switzerland : MDPI AG |
| Abstract: | Two parallel public health epidemics affecting the United States include the COVID-19 pandemic and a rise in substance use disorders (SUDs). Limited research has examined the potential relationship between these two epidemics. Our objective was therefore to perform an exploratory study in order to examine the association between public stigma toward people with a past history of opioid, methamphetamine, cocaine, and alcohol use disorder and COVID-19 vaccine hesitancy. A national sample of U.S. adults (N = 6515) completed a survey which assessed the degree of negative perceptions toward individuals with a past history of substance use disorders (referred to as substance use stigma) and COVID-19 vaccine hesitancy, along with variables such as racial prejudice, source of health news, and other demographics. We evaluated four multivariable logistic regression models to predict COVID-19 vaccine hesitancy, utilizing substance use stigma toward opioids, methamphetamine, cocaine, and alcohol use as independent variables. We found that COVID-19 vaccine hesitancy was positively associated with substance use stigma toward opioid (AOR = 1.34, p < 0.05), methamphetamine (AOR=1.40, p < 0.01), and cocaine (AOR=1.28, p < 0.05) use, but not alcohol use (AOR=1.06, n.s.). Predictive models that incorporate substance use stigma may therefore improve our ability to identify individuals that may benefit from vaccine hesitancy interventions. Future research to understand the underlying reasons behind the association between substance use stigma and COVID-19 vaccine hesitancy may help us to construct combined interventions which address belief systems that promote both substance use stigma and vaccine hesitancy. |
| References: | J Pers Assess. 2003 Feb;80(1):99-103. (PMID: 12584072); Alcohol Clin Exp Res. 2015 Mar;39(3):496-503. (PMID: 25703135); Curr Opin Psychiatry. 2017 Sep;30(5):378-388. (PMID: 28700360); Drug Alcohol Depend. 2021 Dec 1;229(Pt A):109150. (PMID: 34749198); Int J Soc Psychiatry. 2015 Sep;61(6):539-49. (PMID: 25500945); Vaccine. 2021 Oct 29;39(45):6614-6621. (PMID: 34629205); Prev Med. 2022 May;158:107034. (PMID: 35339585); Am J Health Behav. 2001 Sep-Oct;25(5):433-46. (PMID: 11518338); J Subst Abuse Treat. 2019 Apr;99:44-51. (PMID: 30797393); Open Forum Infect Dis. 2021 May 29;8(6):ofab285. (PMID: 34189180); Int J Environ Res Public Health. 2021 Mar 01;18(5):. (PMID: 33804558); Nat Med. 2022 Mar;28(3):456-459. (PMID: 35273403); Addict Behav. 2021 Mar;114:106754. (PMID: 33310690); PLoS One. 2022 Jun 15;17(6):e0269320. (PMID: 35704555); Pathogens. 2023 Jan 19;12(2):. (PMID: 36839435); Prev Med Rep. 2021 Dec 16;25:101673. (PMID: 34934611); JAMA. 2022 Mar 15;327(11):1013-1015. (PMID: 35191947); Soc Sci Med. 2021 Mar;272:113638. (PMID: 33414032); Psychiatr Serv. 2017 May 1;68(5):462-469. (PMID: 28045350); Cultur Divers Ethnic Minor Psychol. 2006 Apr;12(2):275-90. (PMID: 16719577); Subst Use Misuse. 2021;56(12):1752-1764. (PMID: 34315335) |
| Grant Information: | U2C DA050098 United States DA NIDA NIH HHS; UG1DA050066 United States DA NIDA NIH HHS |
| Contributed Indexing: | Keywords: COVID-19; cocaine; methamphetamine; opioids; substance use stigma; vaccine hesitancy |
| Entry Date(s): | Date Created: 20230729 Latest Revision: 20250104 |
| Update Code: | 20260130 |
| PubMed Central ID: | PMC10383134 |
| DOI: | 10.3390/vaccines11071194 |
| PMID: | 37515010 |
| Database: | MEDLINE |
Journal Article